Outbreak of Regulation! Meningitis Outbreak Could Lead to Fewer, More Expensive Drugs

Reports are linking compounded drugs to a large fungal meningitis outbreak that has resulted in over 100 deaths. Compounded drugs escape stringent FDA regulation. The Front Page gang worries that stringent regulations on boutique drug manufacturers could have terrible effects on health care. Hear why as Bill Whittle talks to Rituparna Basu of the Ayn Rand Institute and Terry Jones of IBD about regulations on the pharmaceutical industry.

NOTE: To share or email this 'Specific' article, you must click on the Title of the article.